This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
North Carolina Medical Journal
  • Menu
  • Articles
    • Correspondence
    • Errata
    • From the NCIOM
    • Letters to the Editor
    • Original Research
    • Policy Forum: Columns
    • Policy Forum: Introduction
    • Policy Forum: Invited Commentaries & Sidebars
    • Policy Forum: Issue Brief
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Subscribe
  • COVID-19 Research
  • For Advertisers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:16466/feed
P-ISSN 0029-2559
E-ISSN 2379-4313
Policy Forum: Introduction
Vol. 81, Issue 3, 2020May 01, 2020 EDT

Long-acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use

Erin Major, Carriedelle Wilson Fusco, Zach White, Courtenay Gilmore Wilson, E. Blake Fagan,
Policy Forum
https://doi.org/10.18043/ncm.81.3.210
North Carolina Medical Journal
Major, Erin, Carriedelle Wilson Fusco, Zach White, Courtenay Gilmore Wilson, and E. Blake Fagan. 2020. “Long-Acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use.” North Carolina Medical Journal 81 (3): 210–11. https:/​/​doi.org/​10.18043/​ncm.81.3.210.

View more stats

Powered by Scholastica, the modern academic journal management system